Overview

A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

Multicenter, randomized, open-label, parallel-group exploratory study to explore the effects of azilsartan (Azirva), compared with telmisartan, on insulin resistance in participants with essential hypertension complicated by type 2 diabetes mellitus

Phase:

Phase 4

Details

Lead Sponsor:

Takeda

Treatments:

Azilsartan medoxomil
Telmisartan